Lung cancer screening

3 papers4 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

3 independent labs in 1 country
1 finding against

Funders: National Cancer Institute and others
1 of 4 findings with company ties

Humans3

Outcomes

Lung cancer

upin humans1downin humans1

1 study

Lung cancer screening increases lung cancer in humans (APC, 4.9%).
Humansearly-stage incidencelung2014-2023n = 1,006
Incidence and mortality trends after introduction of lung cancer screening in a community-based healthcare system
Cancer epidemiology4 Sep 2026
Lung cancer screening decreases lung cancer in humans (APC, -5.2%; 95% CI, -9.8% to -0.3%).
Humanslate-stage incidencelung2014-2023n = 1,006
Incidence and mortality trends after introduction of lung cancer screening in a community-based healthcare system
Cancer epidemiology4 Sep 2026

Associations

USPSTF 2013 eligibility criteria

upin humans1

1 study

USPSTF 2013 eligibility criteria is associated with lung cancer screening in humans (64% vs 40% and 32%).
Humanshead and neck cancer survivors meeting 2013 USPSTF criteria
Lung Cancer Screening Among Head and Neck Cancer Survivors
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery11 Sep 2026

Self-efficacy

upin humans1

1 study